gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CG; Kang, JW; Kim, JK; Ko, GY; Kwon, TW; Lim, TH | 1 |
| Alfakih, K; Chiribiri, A; Hussain, S; Ishida, M; Lossnitzer, D; Merkle, N; Morton, G; Nagel, E; Paul, M; Plein, S; Schnackenburg, B; Schuster, A; Steen, H | 1 |
1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Coronary Artery Disease
| Article | Year |
|---|---|
Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Artery Disease; Female; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Reproducibility of Results; Sensitivity and Specificity | 2010 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Coronary Artery Disease
| Article | Year |
|---|---|
Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance.
Topics: Adenosine; Contrast Media; Coronary Artery Disease; Feasibility Studies; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections; Linear Models; Magnetic Resonance Imaging, Cine; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Vasodilator Agents | 2011 |